I agree that this site is using cookies. You can find further informations here.
X
Ozeki, Akichika
35  results:
Search for persons X
?
1

A randomized, double‐blind trial assessing the efficacy and..:

Morioka, Tomoaki ; Takeuchi, Masakazu ; Ozeki, Akichika.
Diabetes, Obesity and Metabolism.  26 (2024)  8 - p. 3167-3175 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Long-term treatment with lasmiditan in patients with migrai..:

Komori, Mika ; Ozeki, Akichika ; Tanji, Yuka...
The Journal of Headache and Pain.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Clinical Evaluation After Discontinuation of Galcanezumab i..:

Takeshima, Takao ; Doi, Hikaru ; Ooba, Satomi...
Neurology and Therapy.  13 (2024)  3 - p. 697-714 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Galcanezumab Efficacy Through the Dosing Interval in Japane..:

Shibata, Mamoru ; Nihira, Atsuko ; Tanji, Yuka...
Neurology and Therapy.  12 (2023)  6 - p. 2007-2019 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Lasmiditan in Japanese Patients with Common Migraine Comorb..:

Kitamura, Shigekazu ; Imai, Noboru ; Tanji, Yuka..
Journal of Pain Research.  16 (2023)  - p. 1725-1738 , 2023
Link: https://doi.org/10.2147/..
 
?
6

Efficacy of Lasmiditan Across Patient and Migraine Characte..:

Takeshima, Takao ; Komori, Mika ; Tanji, Yuka..
Advances in Therapy.  , 2022
Link: https://doi.org/10.1007/..
 
?
7

Safety profile of lasmiditan in patients with migraine in a..:

Hirata, Koichi ; Matsumori, Yasuhiko ; Tanji, Yuka...
Expert Opinion on Drug Safety.  22 (2022)  1 - p. 91-101 , 2022
Link: https://doi.org/10.1080/..
 
?
8

Galcanezumab Effects on Migraine Severity and Symptoms in J..:

Igarashi, Hisaka ; Shibata, Mamoru ; Ozeki, Akichika.
Neurology and Therapy.  12 (2022)  1 - p. 73-87 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Lasmiditan for single migraine attack in Japanese patients ..:

Hashimoto, Yoichiro ; Komori, Mika ; Tanji, Yuka..
Expert Opinion on Drug Safety.  21 (2022)  12 - p. 1495-1503 , 2022
Link: https://doi.org/10.1080/..
 
?
10

Rapid Onset and Sustained Efficacy of Lasmiditan Among Japa..:

Matsumori, Yasuhiko ; Komori, Mika ; Tanji, Yuka..
Neurology and Therapy.  11 (2022)  4 - p. 1721-1734 , 2022
Link: https://doi.org/10.1007/..
 
?
11

A long-term open-label safety study of galcanezumab in Japa..:

Hirata, Koichi ; Takeshima, Takao ; Sakai, Fumihiko...
Expert Opinion on Drug Safety.  , 2021
Link: https://doi.org/10.1080/..
 
?
12

Treatment Satisfaction of Galcanezumab in Japanese Patients..:

Tatsuoka, Yoshihisa ; Takeshima, Takao ; Ozeki, Akichika.
Neurology and Therapy.  10 (2021)  1 - p. 265-278 , 2021
Link: https://doi.org/10.1007/..
 
?
13

Early Onset and Maintenance Effect of Galcanezumab in Japan..:

Igarashi, Hisaka ; Shibata, Mamoru ; Ozeki, Akichika..
Journal of Pain Research.  14 (2021)  - p. 3555-3564 , 2021
Link: https://doi.org/10.2147/..
 
?
14

An Analysis of Extremes: Semiparametric Efficiency in Regre..:

, In: Pioneering Works on Extreme Value Theory; SpringerBriefs in Statistics,
Ozeki, Akichika ; Doksum, Kjell - p. 71-91 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Versi..:

Shibata, Mamoru ; Nakamura, Tomomi ; Ozeki, Akichika..
Journal of Pain Research.  13 (2020)  - p. 3531-3538 , 2020
Link: https://doi.org/10.2147/..
 
1-15